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Abstract High-performance liquid chromatography puri¢ca-
tion followed by mass spectrometry analyses highlighted that
human senile cataractous lens includes a 8182 Da species which
is absent in the normal lens, whereas a 8566/8583 Da species is
present in both lenses. Western blot analysis identi¢ed both
species as ubiquitin. The species at lower molecular weight is
a shorter form due to the cleavage of the C-terminal residues
73^76. As it is the last amino acid of ubiquitin which is involved
in the protein degradation mechanism, we suggest that this
structure modi¢cation compromises the function of ubiquitin
and consequently the physiologically occurring degradation of
the lens proteins.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The mammalian lens mainly consists of proteins, which
account for over 30% of its weight [1]. Their highly ordered
structure is responsible for the transparency of the lens [2].
Numerous changes in crystallin structure occur with age,
mainly due to post translational non-enzymatic reactions
[3] : protein synthesis and turnover are present mainly in the
cortical region, and decrease with age in the nucleus. One
important point to be considered is that lens denatured pro-
teins are not removed by devoted cellular mechanisms; the
numerous proteolytic enzymes which are present in the lens
require structural markers to support their action.
Ubiquitin, a normal component of the lens, conjugate to
proteins as a signal to initiate degradation. In the low molec-
ular weight (LMW) fraction of human crystallins from cata-
ractous lenses, we noted the presence of two forms of ubi-
quitin, one of which was not active, unlike the single form
present in the clear human lenses of age-matched controls.
Due to the age-related increase in sodium and calcium in
the human lens [4], calcium-activated calpain II [5] (EC
34.22.17) may therefore be responsible for the alteration of
the structure and function of ubiquitin, which is no longer
capable of inducing degradation in damaged crystallins.
2. Materials and methods
2.1. Preparation of LMW fraction
The water-soluble fractions were processed by means of high-per-
formance liquid chromatography (HPLC) apparatus (Waters Instru-
ments Model 660) by using two sequential gel ¢ltration BIO-SIL SEC
400 and 250 columns (Bio-Rad), equipped with a diode array photo-
detector. The columns were equilibrated with a 50 mM phosphate
bu¡er, 0.1 M NaCl, pH 6.8 (£ow rate 1 ml/min).
The suitable fractions were pooled, selectively ¢ltered with a 10 kDa
and 3 kDa Centricon ¢lter and concentrated by lyophilization; the
fractions were rechromatographed by reverse-phase (RP)-HPLC by
using an analytical Vydac C18 column (4.6U150 mm) (Separation
Group, Hesperia, CA, USA). The column was equilibrated with
0.01% tri£uoroacetic acid TFA), elution was performed at room tem-
perature with a linear gradient of acetonitrile from 0 to 60% in 40 min
(£ow rate of 1 ml/min). Fractions of 0.2 ml were collected, and ab-
sorbance peaks (260 nm) were pooled and evaporated to dryness. The
dry samples were dissolved in distilled water and subjected to MAL-
DI-TOF (matrix-assisted laser desorption/ionization-time-of-£ight)
and Western blot analyses.
2.2. MALDI-TOF
K-Cyano-4-hydroxy cinnamic acid (Fluka, Buchs, Switzerland) was
used as matrix; the protein or peptide samples (1 Wl from a solution
1 g/l in water) were loaded on the target and dried. Afterwards, 1 Wl of
a solution 10 mg/ml of matrix in a mixture of 0.1% TFA in H2O and
acetonitrile. The samples were analyzed with a Voyager DE-Pro (Per-
Septive Biosystem, Framingham, MA, USA) mass spectrometer oper-
ating either in linear or in re£ector mode.
2.3. Western blot analyses
The puri¢ed LMW fractions were separated by SDS^PAGE on a
20% gel and transferred to nitrocellulose membrane by a Bio-Rad
transfer system. Blotting was performed for 1 h at 100 mA. After
blotting, the membrane was treated with blocking bu¡er (0.2% casein,
1UPBS, 0.1% Tween-20) for 1 h. Thereafter the blot was treated with
the primary antibody (rabbit anti-ubiquitin polyclonal antibody di-
luted 1:1000) for 2 h. The blot was then washed three times with
PBS^Tween for 10 min. Immunoreactivity was detected using conju-
gated antibody anti-rabbit IgG alkaline phosphatase (diluted 1:5000)
by a Western-Light1 immunodetection system (Tropix Company).
3. Results
Non-pathological clear human lenses (68^75 years old), ob-
tained from an Eye Bank, were divided into cortex and nu-
cleus by a sham surgical extracapsular approach. Nuclei from
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total cataractous lenses (age 70^75 years old) were obtained
by surgery. Nuclei were homogenized in a 50 mM phosphate
bu¡er, 0.1 M NaCl, pH 6.8, and centrifuged at 15 000 rpm for
15 min to obtain the water soluble fraction. Analytical HPLC
of this fraction from clear and cataractous lens highlighted the
presence of a very small protein fraction in the region of the
LMW proteins.
This fraction (retention time, rt 23 min) was ¢ltered and
lyophilized. The normalized samples obtained from the nuclei
of both clear and cataractous lenses were rechromatographed
by RP-HPLC by using a Vydac C18 column. Fig. 1A shows
the elution patterns of both samples. There is a clear di¡er-
ence between the areas of the two peaks, eluted at rt 18.6 min
and 34.3 min, respectively, which were collected for further
investigation. The absorption spectra of these fractions (not
shown) highlighted di¡erent features: the ¢rst peak (rt 18.6
min) of both clear and cataractous lenses showed maximum
absorbance centered at 260 nm, with a shoulder at 276 nm,
which may identify a protein complex with a nucleotide co-
factor. The second peak (rt 34.3 min) showed maximum ab-
sorbance at 276 nm in clear lenses, while the maximum shifted
to 274 nm in cataractous lenses. The maximum absorbance at
276 nm is typical of proteins containing tyrosines, but not
tryptophans. The shift at 274 nm, observed in the cataractous
lenses, may have been due to the structural modi¢cation, or
denaturation, of the same protein. Upon denaturation (3 M
urea) of this puri¢ed fraction only one peak, with rt 38 min,
was eluted from both samples (data not shown), with a max-
imum absorbance at 274 nm. This change in elution pattern
may indicate that both peaks obtained in native conditions
may contain the same protein, with or without a cofactor. We
believe that under denaturant conditions, the weak bonds are
broken and the cofactor is released. The shift to a higher
retention time may be a consequence of protein denaturation,
which increases the exposure of hydrophobic side chains.
Each peak obtained from RP-HPLC was analyzed by
MALDI-TOF mass spectrometry (MS) in order to determine
the molecular mass of the actual species. Fig. 1C shows the
mass spectra of the 34.3 rt peaks from the cataractous and the
transparent (inset) human lenses. In the cataractous lens, an
intense peak at 8182 m/z was present, together with two less
intense peaks at 8566 and 8583 m/z ; in the transparent nuclei
fraction, only the 8566 m/z peak was clearly present together
with a barely detectable peak at 8184 m/z. Search in sequence
databases suggests that the value 8566 m/z, which is present in
both spectra, is coincident with the molecular weight of hu-
man ubiquitin (8565 Da), followed by its oxidized form at
8583L 1 Da. The identity of the 34.3 rt peak was con¢rmed
by peptide mapping (see Fig. 2). The peak from transparent
lens was digested using endoproteinase Asp-N, and the result-
ing peptide mixture analyzed by MALDI MS (see Fig. 2a).
Peptides present in the spectrum were sequenced by MALDI
PSD MS and the set of peptides obtained was mapped onto
the known amino acid sequence of ubiquitin (see Fig. 2b),
allowing veri¢cation of the entire sequence of ubiquitin with
the exception of the region 18^31. This unambiguously dem-
onstrated that the HPLC peak under investigation was indeed
ubiquitin, and it also con¢rmed our spectral data, in good
agreement with the absence of tryptophan in human ubiquitin
and the presence of one tyrosine. Spectral features of the 18.6
min rt peak might be due the presence of native ubiquitin and
ATP, which is required for ubiquitin function, or another
nucleotide. The LMW protein (8182 m/z) which is present in
high amounts in cataractous lenses may be an anomalous
product generated by the action of protease. The peptide
map obtained by Endoproteinase Asp-N digestion of the
peak from cataractous lens (see Fig. 2c) was comparable to
that of the control, but contained a further peptide at 1831.3
Da, corresponding to the sequence 58^72, in mixture with the
expected C-terminal peptide 58^76 at 2214.3 Da, both identi-
¢ed by PSD experiments. The same component is observed as
a small trace (8184 m/z) in transparent lenses (68^75 years
old), while it is absent in young transparent lenses (20^23
years old, data not shown). The ratio of three forms observed
in the cataractous lens, i.e. truncated form (8181 m/z), native
form (8566 m/z), and oxidized form (8583 m/z), is approxi-
mately 3:1:1.
As a further support to the identi¢cation of the proteins
under investigation, we performed a Western Blot analysis
using a rabbit polyclonal anti-ubiquitin antibody (Fig. 3).
Only one band proved evident in all the fractions tested
from transparent lens nuclei, thus agreeing with the mass
spectra, which indicated the presence of only one molecular
Fig. 1. RP-HPLC elution pattern by C18 column of LMW fraction
puri¢ed from clear (panel A) and from cataractous lens (panel B).
Elution was carried out at a £ow rate of 1 ml/min, with a gradient
of acetonitrile from 0 to 60% in 40 min. Panel C reports the MAL-
DI-TOF spectrum of the fraction with rt 34.6 min obtained by cata-
ractous lens and by clear lens (inset).
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Fig. 2. Peptide mapping and sequencing by MS. a: MALDI-TOF mass spectrum of the endoproteinase Asp-N digest of the peak at 34.3 rt
from transparent lens in the HPLC separation of Fig. 1A. The peptide fraction was collected from the HPLC separation of Fig. 1, under the
conditions described in Section 2, concentrated to 10 Wl, and then analyzed by MALDI MS. b: MALDI-TOF mass spectrum in post source de-
cay mode of the peptide at 2214.5 m/z in the spectrum of (a) corresponding to the peptide 58^76 from the Endoproteinase Asp-N digest of
ubiquitin (peak at 34.3 rt in the HPLC separation of Fig. 1A) from a normal subject. Signals diagnostics of peptide structure are shown in the
¢gure. c: MALDI-TOF mass spectrum of the endoproteinase Asp-N digest of the peak at 34.3 rt from cataractous lens.
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form. The fraction from cataractous lens nuclei showed two
forms binding anti-ubiquitin antibody, and this was similar to
the mass results which highlighted two peaks (8182 and 8566/
8583 m/z). This heterogeneous content of the peak may ex-
plain the subtle di¡erence of migration, in comparison to the
transparent lens samples, concerning the native ubiquitin
band.
All these results demonstrate that the LMW fraction puri-
¢ed from both clear and cataractous lenses is ubiquitin, in
native and truncated forms.
4. Discussion
Ubiquitin is a signal for protein protection from oxidative
stress [6] or for protein degradation [7]. The proteolytic re-
moval of aged or damaged proteins plays a considerable role
in maintaining lens transparency [8]. Human cataractous
lenses accumulate damaged proteins, so the mechanism of
cataractogenesis may be related to the inactivation of the
protein turnover systems [3].
We puri¢ed two forms of ubiquitin: in the transparent
lenses we found an ubiquitin of 8566 Da, whereas in the
cataractous lenses, we found the presence of an 8566/8583
Da component as well as a truncated form of 8182 Da in
higher amount. It may be hypothesized that ubiquitin is in-
activated by the cleavage of a short segment, either at the N-
terminus or C-terminus. The mass of 8192 Da is in good
agreement with the cleavage of the C-terminus segment 73^
76 (Leu-Arg-Gly-Gly) which generates a truncated ubiquitin
with theoretical mass of 8181.44 Da. The cleavage of segment
1^3 (Met-Gln-Ile) should generate a truncated form with the-
oretical mass of 8192.40 Da. We con¢rmed that the truncated
ubiquitin corresponds to the cleavage of the segment 73^76 by
carboxypeptidase assay, according to the experimental proce-
dure previously described [9]. To study the molecular mecha-
nism of this cleavage in detail, we used molecular graphics
techniques to analyze the three-dimensional structure of hu-
man ubiquitin, solved by X-ray crystallography [10^11] (Fig.
4). According to the CATH classi¢cation [12], ubiquitin is an
K-L roll structure, consisting of a mixed L-sheet (¢ve strands)
and two helices. The last four amino acids (segment 73^76) do
not assume a de¢ned secondary structure (Fig. 4), whereas the
N-terminus segment is involved in an internal strand of the L-
sheet. The disordered region at the C-terminus is well suitable
for proteolytic cleavage, as demonstrated by di¡erent authors
[13^15]. In these articles, it was demonstrated that beta
Fig. 2 (Continued).
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strands are not hydrolyzed by proteases (even if this oppor-
tunity could not be excluded for the external strands, which
may leave the L-sheet, whereas the internal strands are very
strongly constrained). Well exposed segments, without sec-
ondary structure constraints, are the most suitable for proteo-
lytic attack. Furthermore, we found a possible protease to
speci¢cally cleave the segment 73^76. The calcium-activated
neutral proteinase (calpain II, EC 34.22.17) is a component of
lens [5] which preferentially hydrolyzes the peptide bond be-
tween Tyr, Met or Arg residues followed by Leu or Val. In
our case, Arg72 is followed by Leu73 and therefore it consti-
tutes a possible proteolytic site for this proteinase. Abnormal
activation of calpain is known to induce cataract [16^17], and
this phenomenon has been interpreted as the e¡ect of calpain
activity on lens proteins, with the consequent insolubilization
of the proteolytic products. It has to be stressed that, under
physiological conditions, the ubiquitin pathway should de-
grade such products. However, if the ubiquitin is still inacti-
vated by calpain, its function can result strongly reduced. It
must be remembered that, by the mass spectrum (Fig. 1C), the
native ubiquitin appears to be about 1/5 of the total protein
observed, being 1/5 inactivated by oxidation, and 3/5 inacti-
vated by proteolysis.
Modi¢cations occurring at the C-terminal amino acid of
ubiquitin may be responsible for alterations in the protein
degradation mechanism, determining post-translationally
modi¢ed protein accumulation in the lens. In fact, ubiquitin
joins the substrate proteins via an isopeptide linkage between
its carboxyl terminus and the epsilon amino group of an in-
ternal lysine of the target protein. This event is followed by
the formation of a polyubiquitin chain, which once again
requires the linking of the carboxyl terminal group of ubiq-
uitin to the epsilon amino group of Lys48 belonging to an-
other ubiquitin molecule. For this reason, we suggest that one
of the cataractogenesis mechanisms might be induced, or at
least facilitated, by a complex mechanism involving the in-
crease of calcium in lenses, due to aging. A consequent in-
crease in calpain activity, which truncates ubiquitin molecules,
determines the inactivation of ubiquitin-mediated protein deg-
radation mechanisms, bringing about a ¢nal accumulation of
damaged proteins.
In conclusion, HPLC puri¢cation and MS analyses evi-
denced that human senile cataractous lens includes a 8182
Da species which is absent in the normal lens, whereas a
8566/8583 Da species is present in both lenses. Western blot
analysis and MS identi¢ed both species as ubiquitin. The 8182
Da species is due to the cleavage of residues 73^76 at the C-
terminus of the chain. The last amino acid of ubiquitin is
involved in the protein degradation mechanism, thus, we sug-
gest that this structure modi¢cation compromises the function
of ubiquitin and consequently the physiologically occurring
degradation of the lens proteins.
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